Next Article in Journal
Cassava Breeding and Cultivation Challenges in Thailand: Past, Present, and Future Perspectives
Next Article in Special Issue
From Supernatural to Ornamental: Black Elder (Sambucus nigra L., Family Adoxaceae) in Sweden
Previous Article in Journal
In Vitro Biotechnology for Conservation and Sustainable Use of Plant Genetic Resources
Previous Article in Special Issue
Forgotten Gems: Exploring the Untapped Benefits of Underutilized Legumes in Agriculture, Nutrition, and Environmental Sustainability
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 13
Issue 14
10.3390/plants13141898
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective

by
Ebenezer Kwabena Frimpong
1,*,
Nokukhanya Thembane
1,2,
Sphamandla Hlatshwayo
1,
Mlungisi Ngcobo
1 and
Nceba Gqaleni
1,3
1
Traditional Medicine Laboratory, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa
2
Department of Biomedical Sciences, Faculty of Natural Science, Mangosuthu University of Technology, Durban 4026, South Africa
3
Africa Health Research Institute, 3rd Floor K-RITH Tower Building, Nelson R. Mandela School of Medicine, Durban 4001, South Africa
*
Author to whom correspondence should be addressed.
Plants 2024, 13(14), 1898; https://doi.org/10.3390/plants13141898
Submission received: 4 May 2024 / Revised: 4 July 2024 / Accepted: 8 July 2024 / Published: 10 July 2024
(This article belongs to the Special Issue Plants and Peoples: Quo Vadis?)
Browse Figures
Review Reports Versions Notes

Abstract

:
(1) Background: The utilization of medicinal plants in the management of diabetes is of great importance to the health of the indigenous population on the African continent. The high cost of orthodox conventional medicines coupled with the perceived side effects encourages the high patronage of indigenous medicinal plants in the management of this metabolic disorder. We conducted a review on the indigenous African medicinal plants that could be useful in preclinical and clinical trials in the field of diabetes mellitus research. (2) Methods: Data were mined from research articles published and associated with the use of medicinal plants in the management of diabetes on the African continent (from January 2019 to March 2024). Literature from ethnobotanical studies on the African continent was searched from the Google Scholar, SCOPUS, Medline, Web of Science and PubMed databases. We employed the following keywords: “indigenous plants”, “diabetes in Africa” and “antidiabetic effect of medicinal plants”. (3) Results: A total of 52 medicinal plants belonging to 31 families were recorded in this study. Amaryllidaceae (14.28%), Fabaceae (9.52%) and Asteraceae (9.52%) were the most cited plant families. The frequently used indigenous medicinal plants on the African continent were Allium sativum L. (n = 6), Olea europaea L. (n = 6), Azadirachta indica A. Juss (n = 5), Allium cepa L. (n = 5) and Moringa oleifera Lam. (n = 5). The highly cited parts of the plant used in the management of diabetes were the leaves (45.55%), bark (14.44%) and bulbs (12.22%). The preferred methods of the preparation of herbal medicines were decoction (45.23%) and infusion (25%). Oral (52.32%) was the preferred route of the administration of herbal medicine on the African continent. (4) Conclusions: The data revealed some similarities in the way countries on the African continent manage diabetes. This interesting observation will assist in our quest towards obtaining a standardized protocol using indigenous medicinal plants to combat diseases on the African continent.

1. Introduction

Diabetes mellitus (DM) is one of the major diseases associated with morbidity and mortality on the African continent. The literature suggests that about 19 million adult people in Africa have diabetes [1]. More importantly, a study conducted by Shaw et al. [2] revealed that the Asia and Africa regions present the greatest risks because the prevalence rate could rise threefold in the not-too-distant future. DM is categorized as a triangular disorder that involves complex interactions among fats, carbohydrates and pancreatic enzymes such as glucagon and insulin. The energy that the cells in humans utilizes to function optimally originates from proteins, carbohydrates and lipids. The glucose released into circulation from the liver is the product of carbohydrate ingestion. Pancreatic β cells release the hormone insulin so that it can interact with specific cellular receptors to ensure the entry of glucose into the cells. The insulin obtained from the pancreatic β cells facilitates the entry of glucose into the cells for its energy conversion [3]. According to the World Health Organization (WHO), DM is characterized by a fasting plasma glucose value of about 126 mg/Dl (7 mmol/L), or a higher value recorded on two separate tests [4]. The four major classifications of diabetes include Type 1, Type 2, gestational and diabetes specifically induced by drugs, cystic fibrosis and latent-action disease in adults [5]. The major symptoms of diabetes include blurred vision and polyuria [6], and the major complications of the disease are atherosclerosis, chronic kidney disease, nerve damage, retinopathy and heart attack [7]. Diabetes is managed with insulin, pharmacotherapy and diet [8,9]. It is significant to point out that even though orthodox conventional medicine (OCM) assists in the management of diabetes, its use is associated with side effects such as heart and liver diseases and skin rashes [10]. The side effects associated with the use of OCM (Table 1 and Table 2) to manage diabetes encourage patients to rely on African traditional medicine (ATM) [11]. The high patronage of ATMs, mainly herbal mixtures, in the management of diabetes on the African continent is due to their affordability and their perceived lack of side effects [12].
A study revealed that medicinal plants play an important role in the management of diabetes [13]. These medicinal plants are effective in the management of diabetes because of their phytochemical constituents, such as flavonoids, glycosides and carotenoids, which act as anti-hyperglycemic agents [14]. The literature suggests that the antidiabetic potential of the phytochemical constituents present in medicinal plants could be due to their effect on the glycogenesis stimulation coupled with the decrease in glucose absorption and the activation of β cells to release insulin to assist in glucose use in patients [15,16]. Furthermore, these phytochemical constituents associated with medicinal plants could assist in the termination of oxidative stress on β cells. These phytochemical constituents can also restore impaired β cells [17,18].
Considering the use of medicinal plants in the management of diabetes in Africa, it is important to assist the scientific community with the most common plants for further studies in the quest to mitigate the effects of the disease in our societies. This review aims to provide information about the medicinal plants used in the management of diabetes on the African continent over the last 5 years (2019–2024).
Table 1. Orthodox conventional medicines used in the management of DM (oral hypoglycemic drugs).
Table 1. Orthodox conventional medicines used in the management of DM (oral hypoglycemic drugs).
ClassificationDrugs and Their
Synonyms		Mechanism of ActionPharmacological EffectsSide Effects
Sulfonylurea derivativesGlibenclamide,
glicaside		Assist in the stimulation of the endogenic insulin production of β cells of the pancreas [19]Hypoglycemic, hypolipidemicWeight gain [20]
Biguanide derivativesMetformin, buforminOverpowering of gluconeogenesis in the liver, lipolysis stimulation, uptake of glucose utilization by peripheral tissues and reduction in glucose absorption in the gastrointestinal tract [21]Hypoglycemic, fibrinolytic and anorexigenicGastrointestinal disturbance, lactic acidosis [22]
MeglitinidesRepaglinide, nateglinideHelps in the reduction in the blood glucose levels by stimulating the production of insulin [23]HypoglycemicDizziness and headache [24]
ThiazolidinedionesPioglitazone, rosiglitazoneAssist in the activation of the nuclear peroxisome proliferator receptor-gamma (PPAR-gamma), thereby increasing the insulin action and decreasing the blood glucose [25]Anti-hyperglycemic, hypoglycemicWeight gain, cardiac hypertrophy, pulmonary edema [26,27,28]
Alpha glucose inhibitorsAcarbose, miglitolAssist in the reduction in the blood glucose levels via the delay of digestion and the absorption of multifaceted carbohydrates [29]HypoglycemicGastrointestinal disturbance [30]
Table 2. Orthodox conventional medicines applied in the management of DM (Insulin).
Table 2. Orthodox conventional medicines applied in the management of DM (Insulin).
ClassificationDrugs and Their SynonymsMechanism of ActionPharmacological EffectsSide Effects
Human origin
Short-term actingHumalog, ActrapidAssist in the regulation of carbohydrate metabolism, the promotion of the transportation of glucose inside the cells and its assimilation by the tissues; helps in the increment of glycogenesis, protein and fatty acid synthesis [31]Hypoglycemic effectMild burning sensation in the nostrils of patients [32]
Medium-term actingHumulin, MonotardAssist in the regulation of carbohydrate metabolism, the promotion of the transportation of glucose inside the cells and its assimilation by the tissues [33]Hypoglycemic effectVomiting, dizziness [34]
Long-term actingUltratardAssists in the regulation of the carbohydrate metabolism, the promotion of the transportation of glucose inside the cells and its assimilation by the tissues; helps in the increment of glycogenesis, protein and fatty acid synthesis [35]Hypoglycemic effectIncidence of myocardial infarctions [36]
Animal origin
Short-term actingMonoinsulinAssists in the regulation of the carbohydrate metabolism, the promotion of the transportation of glucose inside the cells and its assimilation by the tissues; helps in the increment of glycogenesis, protein and fatty acid synthesis [37]Hypoglycemic effectSevere hypoglycemic episodes [38]
Medium-term actingInsulin Semilente, B-insulin-SAssist in the regulation of the carbohydrate metabolism, the promotion of the transportation of glucose inside the cells and its assimilation by the tissues; helps in the increment of glycogenesis, protein and fatty acid synthesis [39]Hypoglycemic effectLipoatrophy on the patient’s thighs [40]
Long-term actingUltralenteAssists in the regulation of the carbohydrate metabolism, promotion of the transportation of glucose inside the cells and its assimilation by the tissues; helps in the increment of glycogenesis, protein and fatty acid synthesis [37]Hypoglycemic effectIncrease in the body weights of patients [41]

2. Methods

2.1. Selection of Publications Employed in This Study

We carried out the research by employing a combination of the following words: “indigenous medicinal plants”, “diabetes in Africa”, “antidiabetic effect of medicinal plants”, “hypoglycemic activity of medicinal plants” and “indigenous preparations of herbal mixtures”. Employing the Google Scholar, SCOPUS, Medline, Web of Science and PubMed databases, published articles were accessed for possible inclusion in this study.

2.2. An Overview of the Selection Procedure Used in This Study

Generally, the inclusion criteria were published articles written in the English language (from January 2014 to March 2024), the provision of the scientific name of the medicinal plant and the location of the study area on the African continent. The exclusion criteria involved articles not written in the English language, literature or systematic review articles, work related to the use of OCM in the management of diabetes, abstract-only researched articles and case reports, books, manuals and related studies reporting animal-/mineral-based African traditional medicine (ATM) employed in the management of diabetes. The authors did employ a four-step selection criterion process to identify potential articles relevant to this study. To begin with (Step 1), the relevance of the identified published articles was assessed based on their captions and recorded on a data sheet. Secondly, abstracts of the published studies were assessed for their conformity to the inclusion criteria. Thirdly, the authors obtained full-length texts from the identified published articles based on the knowledge acquired in Step 2 to make an informed decision as to whether to add or reject these publications in this review. Lastly, the published research articles that satisfied the inclusion criteria mapped out by the authors were collated for this study. A total of 39 research articles were identified and included in this study (Figure 1). The data were scrutinized to extract relevant information, such as botanical names, local names, countries, routes of administration and modes of preparation (Table 3). Employing recognized databases such as the Plant List and Plant ZA databases (including the Global Biodiversity Information Facility database), the botanical names of the medicinal plants captured in this study were validated [42,43].

3. Results and Discussion

3.1. Patterns and Distributions of Medicinal Plants Utilized in the Management of Diabetes in Africa

In this study, we recorded 39 eligible studies (Figure 1) based on our search criteria (Section 2.1) from different regional blocs on the African continent. Our data revealed that the Western African Region (WAR) recorded the highest number of studies (n = 13), followed by the Northern African Region (NAR) (n = 12), Southern African Region (SAR) (n = 7), Eastern African Region (EAR) (n = 6) and Central African Region (CAR) (n = 1). Regarding the countries that recorded the highest numbers of studies, Nigeria recorded one of the highest (n = 8). The other African countries that made the list are as follows: Morocco (n = 8), Algeria (n = 3) and South Africa (n = 4). A total of 52 medicinal plants representing 31 families were included in this review. This study has shown that, notwithstanding the geographical location on the African continent, the use of medicinal plants in the management of diabetes is of great prevalence. Similarly, the application of medicinal plants in the management of diabetes on different continents has been established in other studies [82,83].

3.2. Assessed Medicinal Plants and Families Used in Diabetes Management on the African Continent

Our study revealed that the most dominant plant families were Amaryllidaceae (14.28%), Fabaceae (9.52%), Asteraceae (9.52%) and Meliaceae (7.14%) (Figure 2). This is largely in agreement with a study conducted by van Wyk (2020), which revealed that the most dominant plant families in sub-Saharan Africa are Fabaceae (567 spp., 156 genera), Lamiaceae (142 spp., 37 genera) and Asteraceae (314 spp., 112 genera) [84]. Interestingly, similar studies around the globe have mentioned the association of these plant families with the management of diabetes in their respective geographical areas [85,86]. Scientific data revealed the antidiabetic potency of the Amaryllidaceae family due to the presence of their secondary metabolites (flavonoids and alkaloids), which assist in decreasing blood glucose levels [87]. The Fabaceae family’s antidiabetic potential is based on their alpha-amylase inhibitory effects in organisms [88]. The Meliaceae family’s antidiabetic potential could also be due to their ability to inhibit alpha-amylase [89]. Bessada et al. [90] reported the antidiabetic potential of the Asteraceae family due to its stronger antioxidant properties, which assist in diabetes management. The most cited plant species in this study were Azadirachta indica A. Juss (n = 6), Allium sativum L. (n = 6), Olea europaea L. (n = 6), Allium cepa L. (n = 5) and Moringa Oleifera Lam. (n = 5) (Table 3). It is significant to point out that experimental data confirmed the antidiabetic potential of the most cited plant species in this study. For example, meliacinolin (novel tetranortriterpenoid) extracted from Azadirachta indica A. Juss repressed the alpha-amylase and alpha-glucosidase enzyme inhibitory activities in mice with streptozotocin (STZ)-induced diabetes [91]. Similarly, the oral administration of garlic extracts to rats with STZ-induced diabetes improved the serum glucose and cholesterol levels in the experimental animals [92]. The above-explained experimental models using some of the most cited plant species recorded in this study justify the utilization of these indigenous medicinal plants within traditional African communities. However, the issue of the safety and use of medicinal plants should be taken into consideration, as recommended by the WHO policy on alternative medicine [93]. Kharchoufa et al. [94] argued that the perception regarding medicinal plant use in the management of diseases might not be entirely true. This is because of the adverse effects associated with the use of medicinal plants, such as carcinogenicity, teratogenicity and even death [94]. A study revealed that the use of medicinal plants may be toxic when taken together with drugs [95]. Ponnusankar et al. [95] reiterated the need to encourage research-related activities associated with herb–drug interactions. Furthermore, the authors recommended the evaluation of herbal medicines to determine their efficacy before their application in the management of diseases [95].

3.3. Commonalities in the Utilization of Similar Medicinal Plants in the Management of Diabetes on the African Continent

This study has shown similarities in the use of certain medicinal plants in the management of diabetes on the African continent (Table 3). For example, Allium cepa L., used in the management of diabetes in Ghana [49], is also used in the management of diabetes in Algeria [50] and Uganda [79]. Interestingly, the traditional use of Allium cepa L. in the management of diabetes has been well documented in studies conducted in Jordan [96] and India [97]. Moringa oleifera Lam., which is utilized in the management of diabetes in Nigeria [54], is also used in Angola [60] and Zambia [53] for similar purposes. Fascinatingly, ethnobotanical studies in Barbados [98] and the Philippines [99] revealed the use of Moringa oleifera Lam. by participants in the management of diabetes. This interesting observation (similarities associated with the use of medicinal plants [49,50,53,54,60,79]) is important to assist in the development of standardized health protocols using indigenous medicinal plants for the treatment and management of various diseases on the African continent. The development of a standardized health protocol employing indigenous medicinal plants to manage diseases on the continent will be possible with the assistance of traditional health practitioners (THPs) in various African countries. Studies have shown that THPs on the African continent are always reluctant to provide information about the constituents of the herbal preparations they employ to manage diseases. The THPs think that scientific researchers make use of their knowledge without acknowledging their contributions to the development of indigenous medicinal plant research on the continent [46,100]. There is a need to ensure proper agreements that will ensure the protection of THP rights between all the stakeholders involved in the management of diseases on the continent. These intellectual property (IP) agreements between scientific researchers and THPs on the African continent must be respected. An exchange program (involving THPs and academia) to share ideas regarding the treatment of diseases among the various African countries should be encouraged.

3.4. Plant Parts Used in the Management of Diabetes on the African Continent

The most identified plant parts used in the management of diabetes on the African continent were as follows: leaves (45.55%), bark (14.44%), bulb (12.22%) and roots (8.88%) (Figure 3). This is incongruent with other studies around the globe that cite leaves as the preferred plant parts employed in the preparation of herbal medicines to manage diabetes [101,102]. The preferred application of leaves in herbal preparations could be because leaves pose a limited threat to the survival of the plant species in indigenous communities [103]. Hamel et al. [104] argued that the high patronage of the leaves in the preparation of herbal medicines is justified because of the chemical compounds stored in the organ as a result of the synthesis of secondary metabolites [104].

3.5. Methods of Preparation Used in the Management of Diabetes on the African Continent

The preferred methods of preparation are predominantly decoction (46.43%), infusion (25%) and maceration (11.90%) (Figure 4). This is in agreement with studies carried out in India in which decoction was the preferred method of the preparation of herbal medicines [105]. Similarly, Amal and Masarrat [106] reported that decoction was the preferred mode of the preparation of herbal medicines in a study conducted in Saudi Arabia. It is significant to point out that the preferred methods of the preparation of herbal medicines (mainly decoction and infusion) by traditional healers in the management of diabetes on the African continent could be due to its affordability and the lower amount of energy applied in terms of the preparation [107]. The limited use of roots in the preparation of herbal medicines, even though they are known to be rich in phytochemical constituents, is because their use poses a challenge to the survival of the indigenous medicinal plants in traditional African communities [108].

3.6. Route of Administration of the Medicinal Plants Used in the Management of Diabetes in Africa

Findings from this study revealed that the predominant route of administration is oral (52.32%) (Figure 5). This is like other studies that revealed that the preferred route of the administration of herbal medicines in the management of diabetes is the oral route [109,110]. Significantly, Lebbie et al. reported that the oral route of the administration of herbal medicines is a non-invasive and highly effective method [111].

4. Conclusions

This study demonstrates that there is an enormous diversity of indigenous medicinal plants utilized in the management of diabetes on the African continent. The highly cited indigenous medicinal plants in this study are Azadirachta indica, Allium sativum, Moringa Oleifera and Olea europaea. The medicinal plants documented in this study could assist researchers in developing novel medicines for the treatment of diabetes on the African continent and beyond. Fascinatingly, metformin, an oral hypoglycemic drug, was obtained from a medicinal plant (Galega officinalis) [112]. The contributions of the data presented in this study to the scientific community in our quest to find novel medicines to mitigate the effect of diabetes in our communities cannot be overstated. There is a need to conduct a comprehensive isolation of the biologically active components in the identified medicinal plants for pharmacological analysis purposes, and to determine their curative properties. To this end, extensive preclinical and clinical trials should be conducted using the medicinal plants frequently cited in this study to determine their antidiabetic potential. The employment of toxicological techniques to predict the safety of the isolated bioactive compounds from the documented indigenous medicinal plants in this study is highly recommended.

Author Contributions

Conceptualization, E.K.F.; methodology, E.K.F.; investigation, E.K.F.; N.T. and S.H.; formal analysis, E.K.F.; review and editing, N.G. and M.N. All authors have read and agreed to the published version of the manuscript.

Funding

FEK was funded by the postdoctoral research fellowship from the College of Health Sciences, University of KwaZulu-Natal.

Data Availability Statement

Data are contained within the article.

Acknowledgments

We appreciate the institutional support from the Dean of Research Office (College of Health Sciences), University of KwaZulu-Natal.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. International Diabetes Federation Diabetes. Atlas, 9th ed.; IDF: Brussels, Belgium, 2019; Available online: https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf (accessed on 25 March 2024).
  2. Shaw, J.E.; Sicree, R.A.; Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4–14. [Google Scholar] [CrossRef] [PubMed]
  3. Turkoski, B.B. Diabetes and diabetes medications. Orthop. Nurs. 2006, 25, 227–231. [Google Scholar] [CrossRef]
  4. Available online: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/2380# (accessed on 25 March 2024).
  5. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021, 44, S15–S33. [Google Scholar] [CrossRef]
  6. Ramachandran, A. Know the signs and symptoms of diabetes. Indian J. Med. Res. 2014, 140, 579. [Google Scholar] [PubMed]
  7. Deshpande, A.D.; Harris-Hayes, M.; Schootman, M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 2008, 11, 1254–1264. [Google Scholar] [CrossRef] [PubMed]
  8. Zimmet, P.; Alberti, K.; Shaw, J. Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782–787. [Google Scholar] [CrossRef] [PubMed]
  9. Miller, C.D.; Phillips, L.S.; Ziemer, D.C.; Gallina, D.L.; Cook, C.B.; El-Kebbi, I.M. Hypoglycemia in patients with type 2 diabetes mellitus. Arch. Intern. Med. Res. 2001, 161, 1653–1659. [Google Scholar] [CrossRef] [PubMed]
  10. Kane, M.P.; Abu-Baker, A.; Busch, R.S. The utility of oral diabetes medications in type 2 diabetes of the young. Curr. Diabetes Rev. 2005, 1, 83–92. [Google Scholar] [CrossRef] [PubMed]
  11. Frimpong, E.; Nlooto, M. Management of diabetes and hypertension among Tswana and Zulu traditional health practitioners: A comparative cross-sectional study using a mixed-methods approach. Afr. J. Biomed. Res. 2020, 23, 135–146. [Google Scholar]
  12. Frimpong, E.; Nlooto, M. Tswana traditional health practitioners’ perspectives on the management of diabetes and hypertension: A qualitative study using focus group discussions. Pan. Afr. Med. J. 2019, 34, 1–11. [Google Scholar] [CrossRef]
  13. Yakubu, M.T.; Sunmonu, T.O.; Lewu, F.B.; Ashafa, A.O.; Olorunniji, F.J.; Eddouks, M. Medicinal plants used in the management of diabetes mellitus. Evid. Based Complement. Altern. Med. 2015, 2015, 467196. [Google Scholar] [CrossRef]
  14. Govindappa, M. A review on role of plant(s) extracts and its phytochemicals for the management of diabetes. J. Diabetes Metab. 2015, 6, 1000565. [Google Scholar]
  15. Shewasinad, A.; Bhoumik, D.; Zero Hishe, H.; Masresha, B. Antidiabetic activity of methanol extract and fractions of Thymus schimperi Ronniger leaves in normal and streptozotocin induce diabetic mice. Iran. J. Pharmacol. Ther. 2018, 16, 1–8. [Google Scholar]
  16. Shewamene, Z.; Abdelwuhab, M.; Birhanu, Z. Methanolic leaf exctract of Otostegia integrifolia Benth reduces blood glucose levels in diabetic, glucose loaded and normal rodents. BMC Complement. Altern. Med. 2015, 15, 19. [Google Scholar] [CrossRef]
  17. Upadhyay, S.; Dixit, M. Role of polyphenols and other phytochemicals on molecular signaling. Oxid. Med. Cell. Longev. 2015, 2015, 504253. [Google Scholar] [CrossRef] [PubMed]
  18. Kifle, Z.D.; Yesuf, J.S.; Atnafie, S.A. Evaluation of in vitro and in vivo anti-diabetic, anti-hyperlipidemic and anti-oxidant activity of flower crude extract and solvent fractions of Hagenia abyssinica (rosaceae). J. Exp. Pharmacol. 2020, 12, 151–167. [Google Scholar] [CrossRef] [PubMed]
  19. Rendell, M. The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004, 64, 1339–1358. [Google Scholar] [CrossRef]
  20. Kar, P.; Holt, R.I.G. The Effect of Sulphonylureas on the Microvascular and Macrovascular Complications of Diabetes. Cardiovasc. Drug Ther. 2008, 22, 207–213. [Google Scholar] [CrossRef] [PubMed]
  21. Rena, G.; Hardie, D.G.; Pearson, E.R. The mechanisms of action of metformin. Diabetologia 2017, 60, 1577–1585. [Google Scholar] [CrossRef]
  22. Samson, S.L.; Garber, A.J. Metformin and other biguanides: Pharmacology and therapeutic usage. Int. Textb. Diabetes Mellitus 2015, 641–656. [Google Scholar]
  23. Meneses, M.; Silva, B.; Sousa, M.; Sá, R.; Oliveira, P.; Alves, M. Antidiabetic drugs: Mechanisms of action and potential outcomes on cellular metabolism. Curr. Pharm. Des. 2015, 21, 3606–3620. [Google Scholar] [CrossRef] [PubMed]
  24. Jovanovic, L.; Dailey, G.; Huang, W.C.; Strange, P.; Goldstein, B.J. Repaglinide in type 2 diabetes: A 24-week, fixed-dose efficacy and safety study. J. Clin. Pharmacol. 2000, 40, 49–57. [Google Scholar] [PubMed]
  25. Hauner, H. The mode of action of thiazolidinediones. Diabetes Metab. Res. Rev. 2002, 18, S10–S15. [Google Scholar] [CrossRef] [PubMed]
  26. Ovalle, F.; Ovalle-Berúmen, J.F. Thiazolidinediones: A review of their benefits and risks. South Med. J. 2002, 95, 1188–1194. [Google Scholar] [CrossRef] [PubMed]
  27. Williams, G.; Deldar, A.; Jordan, W.; Gries, C.; Long, G.; Dimarchi, R. Subchronic toxicity of the thiazolidinedione, Tanabe-174 (LY282449), in the rat and dog. Diabetes 1993, 42, A59. [Google Scholar]
  28. Hirsch, I.B.; Kelly, J.; Cooper, S. Pulmonary edema associated with troglitazone therapy. Arch. Intern. Med. 1999, 159, 1811–1817. [Google Scholar] [CrossRef] [PubMed]
  29. Derosa, G.; Maffioli, P. α-Glucosidase inhibitors and their use in clinical practice. Arch. Med. Sci. 2012, 8, 899. [Google Scholar] [CrossRef] [PubMed]
  30. Lebovitz, H.E. Alpha Glucosidase Inhibitors. Endocrinol. Metab. Clin. North Am. 1997, 26, 539–551. [Google Scholar] [CrossRef] [PubMed]
  31. Available online: https://uspl.lilly.com/humalog7525/humalog7525.html#pi (accessed on 25 March 2024).
  32. Guthoff, M.; Stingl, K.T.; Tschritter, O.; Rogic, M.; Heni, M.; Stingl, K.; Hallschmid, M.; Häring, H.-U.; Fritsche, A.; Preissl, H. The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects. PLoS ONE 2011, 6, e19482. [Google Scholar] [CrossRef]
  33. Available online: https://pdf.hres.ca/dpd_pm/00034827.PDF (accessed on 25 March 2024).
  34. Allister, C. Cardiac arrest after crush injury. Br. Med. J. (Clin. Res. Ed) 1983, 287, 531–532. [Google Scholar] [CrossRef]
  35. Davies, R.; McEwen, J.; Moreland, T.; Durnin, C.; Newton, R. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin—A comparison of multiple injection regimens. Diabetes Med. 1988, 5, 671–675. [Google Scholar] [CrossRef] [PubMed]
  36. Heller, S.R. A summary of the Advance Trial. Diabetes Care 2009, 32 (Suppl. 2), S357–S361. [Google Scholar] [CrossRef] [PubMed]
  37. Available online: https://pharmacolpharmacother.nuph.edu.ua/wp-content/uploads/2018/09/Pharmacology-on-your-palms.pdf (accessed on 25 March 2024).
  38. Kuroe, A.; Taniuguchi, A.; Fukushima, M.; Nakai, Y.; Ohgushi, M.; Ohya, M.; Seino, Y. Early and late onset side effects of short-acting insulin analogue in seven Japanese diabetic patients. Diabetes Res. Clin. Prac. 2007, 77, 412–413. [Google Scholar] [CrossRef] [PubMed]
  39. Skyler, J.S. Insulin Pharmacology. Med. Clin. North Am. 1988, 72, 1337–1354. [Google Scholar] [CrossRef] [PubMed]
  40. Teuscher A: Treatment of insulin lipoatrophy with monocomponent insulin. Diabetologia 1974, 10, 211–214. [CrossRef] [PubMed]
  41. Turner, R.C.; Mann, J.I.; Iceton, G.; Oakes, S.; Smith, A.; Moore, J.; Hockaday, T.D.R.; Holman, R.R.; Stowers, J.; Stowers, M. UK prospective study of therapies of maturity-onset diabetes. Diabetologia 1983, 24, 404–411. [Google Scholar] [CrossRef] [PubMed]
  42. Available online: https://wfoplantlist.org/ (accessed on 25 March 2024).
  43. Available online: https://pza.sanbi.org/ (accessed on 25 March 2024).
  44. Ajao, A.A.-N.; Mukaila, Y.O.; Kenkpen, D.Y. An ethnobotanical study of medicinal plants used to treat and manage diabetes mellitus in Ede, Osun State Nigeria. Ethnobot. Res. Appl. 2023, 25, 1–18. [Google Scholar] [CrossRef]
  45. Ogunkalu, O.; Adelani, D.; Ariyo, O.; Ogunsanwo, J.; Odeyale, A. Ethno-Medicinal Survey of Plants Used for the Management of Diabetes Mellitus in Kaduna Metropolis, Kaduna State. Niger. Agric. J. 2022, 53, 262–273. [Google Scholar]
  46. Frimpong, E.; Nlooto, M. Management of diabetes and hypertension among Zulu traditional health practitioners: A study of focus group interviews. Ethiop. J. Health Dev. 2019, 33, 4. [Google Scholar]
  47. Bouzabata, A.; Mahomoodally, M.F. A quantitative documentation of traditionally used medicinal plants from Northeastern Algeria: Interactions of beliefs among healers and diabetic patients. J. Herb. Med. 2020, 22, 100318. [Google Scholar] [CrossRef]
  48. Abubakar, M.; Abdullahi, H.; Muhammad, Z.A.; Hussein, A.M.; Lawal, A. Survey of Some Medicinal Plants Employed for Managing Diabetes Mellitus in Hadejia Town, Nigeria. East Afr. J. Health Sci. 2021, 3, 12–19. [Google Scholar] [CrossRef]
  49. Firempong, C.K.; Addo-Fordjour, P.; Komlaga, G.; Ameyaw, Y.; Nirvana, N.O.; Frederick, K.; Yaw, A. Ethnobotanical study of medicinal plants used to treat HIV, cancer and diabetes in some communities of Ashanti Region, Ghana. J. Herb. Med. 2023, 39, 100648. [Google Scholar] [CrossRef]
  50. El Hachlafi, N.; Chebat, A.; Bencheikh, R.S.; Fikri-Benbrahim, K. Ethnopharmacological study of medicinal plants used for chronic diseases treatment in Rabat-Sale-Kenitra region (Morocco). Ethnobot. Res. Appl. 2020, 20, 1–23. [Google Scholar] [CrossRef]
  51. Sidiq, L.O.; Segun, P.A.; Ogbole, O.O. Medicinal plants used in four Local Government Areas of South-western Nigeria for the managements of diabetes and its comorbidities: An ethnobotanical survey. Res. Sq. 2020, 1–17. [Google Scholar] [CrossRef]
  52. Djahafi, A.; Taïbi, K.; Abderrahim, L.A. Aromatic and medicinal plants used in traditional medicine in the region of Tiaret, North West of Algeria. Medit. Bot. 2021, 42, e71465. [Google Scholar] [CrossRef]
  53. Hikaambo, C.; Namutambo, Y.; Kampamba, M.; Mufwambi, W.; Kabuka, R.; Chulu, M.; Nanyangwe, N.; Banda, M.; Chimombe, T.; Muungo, L.T. Prevalence and Patterns of Herbal Medicine Use among Type 2 Diabetes Mellitus Patients at the University Teaching Hospitals in Lusaka. J. Biomed. Res. Environ. Sci. 2022, 3, 74–81. [Google Scholar] [CrossRef]
  54. Bamisaye, F.; Ajuwon, O.; Ajiboye, B.; Oluwajobi, O.; Adejumo, A. Ethnobotanical Survey and Antioxidant Potentials of Selected Medicinal Plants in the Management of Diabetes Mellitus in Efon Alaaye, Ikole, and Oye Local Government Areas in the Southwest of Ekiti State, Nigeria. J. Pure Appl. Sci. 2023, 8, 10–28. [Google Scholar]
  55. Yazit, S.M.; Bousaid, M.; Abderrahim, L.A.; Kaddour, K.; Bouakkaz, M.A.; Souana, K.; Abdelkader, T.; Taibi, K. Medicinal plants used for the traditional Management of Diabetes Mellitus in the region of Tiaret, Algeria. Int. J. Ecosyst. Ecol. Sci. 2023, 13, 305–312. [Google Scholar] [CrossRef]
  56. Fouad, Z.; Lahcen, Z. Antidiabetic Medicinal Plants in Morocco: Ethnobotanical Survey of The Population of Beni Mellal. Plant Arch. 2020, 20, 09725210. [Google Scholar]
  57. Kingo, R.M.; Maregesi, S.M. Ethnopharmacological study on some medicinal plants used in Ujiji, Kigoma, Tanzania. J. Pharmacol. 2020, 9, 102–109. [Google Scholar] [CrossRef]
  58. Shopo, B.; Mapaya, R.J.; Maroyi, A. Ethnobotanical study of medicinal plants traditionally used in Gokwe South District, Zimbabwe. S. Afr. J. Bot. 2022, 149, 29–48. [Google Scholar] [CrossRef]
  59. Olufemi Adepoju, A.; Oyedeji Amusa, M.; Oluwasegun Samson, A.; Okechukwu Paul-Chima, U. Ethnopharmacological survey on medicinal plants utilization in Freetown, Sierra Leone. RPS Pharm. Pharmacol. Rep. 2023, 2, rqad019. [Google Scholar] [CrossRef]
  60. Canga, I.L.V.; Vita, P.; de Pinho, C.M.L.; González, M.Á.C. Ethnopharmacological study of medicinal plants from the province of Cuanza Norte (Angola). Revis. Contexto Saúde 2022, 22, e13336. [Google Scholar] [CrossRef]
  61. Adam, M.; Ahmed, A.A.; Yagi, A.; Yagi, S. Ethnobotanical investigation on medicinal plants used against human ailments in Erkowit and Sinkat areas, Eastern Sudan. Biodiversitas 2020, 21, 7. [Google Scholar] [CrossRef]
  62. Hayat, J.; Mustapha, A.; Abdelmajid, M.; Mourad, B.; Ali, S.; Said, E.; Saadia, B. Ethnobotanical survey of medicinal plants growing in the region of “Oulad Daoud Zkhanine” (Nador Province), in Northeastern Morocco. Ethnobot. Res. Appl. 2020, 19, 1–12. [Google Scholar]
  63. Bekoe, E.O.; Agyare, C.; Boakye, Y.D.; Baiden, B.M.; Asase, A.; Sarkodie, J.; Nettey, H.; Adu, F.; Otu, P.B.; Agyarkwa, B. Ethnomedicinal survey and mutagenic studies of plants used in Accra metropolis, Ghana. J. Ethnopharmacol. 2020, 248, 112309. [Google Scholar] [CrossRef] [PubMed]
  64. Idm’hand, E.; Msanda, F.; Cherifi, K. Ethnobotanical study and biodiversity of medicinal plants used in the Tarfaya Province, Morocco. Acta Ecol. Sin. 2020, 40, 134–144. [Google Scholar] [CrossRef]
  65. Ndombe, R.T.; Mutambel’hity, D.S.N.; Lubini, C.A.; Idrissa, A.Z.; Ibekeke, Y.B.S.; Divengi, J.-P.N. Catalog of antidiabetic medicinal plants from the endogenous knowledge of the Wongos of the Idiofa territory in the DR Congo. Magna Sci. Adv. Res. Rev. 2022, 5, 19–26. [Google Scholar] [CrossRef]
  66. Musa, D.D.; Oti, E.C.; Buah, J.D.; Hafiz, S.S.; Mohammed, R. Ethnobotanical Survey of Plants Used in Treatment of Diabetes by the Hausa-Fulani Tribals in Katsina State Nigeria. Int. J. Pure Appl. Sci. 2022, 31, 68–80. [Google Scholar]
  67. Chetoui, A.; Kaoutar, K.; Boutahar, K.; El Kardoudi, A.; BenChaoucha-Chekir, R.; Chigr, F.; Najimi, M. Herbal medicine use among Moroccan type 2 diabetes patients in the Beni Mellal-Khenifra region. J. Herb. Med. 2021, 29, 100480. [Google Scholar] [CrossRef]
  68. El-Ghazouani, F.; Nadia, E.O.; Teixidor Toneu, I.; Bouchra, Y.; Zekhnini, A. A survey of medicinal plants used in traditional medicine by women and herbalists from the city of Agadir, South-West of Morocco. Eur. J. Integr. Med. 2021, 42, 101284. [Google Scholar] [CrossRef]
  69. Otieno, J.N. Informant consensus for anti-diabetic medicinal plants by traditional healers in Tanzania. J. Med. Plants 2022, 10, 6–12. [Google Scholar]
  70. Williams, V.L.; Burness, A.; Byrne, M.J. Medicinal plants sold by west, central and East african immigrants in Johannesburg, South Africa. Trans. R. Soc. S. Afr. 2022, 77, 7747–7762. [Google Scholar] [CrossRef]
  71. Yebouk, C.; Redouan, F.Z.; Benítez, G.; Bouhbal, M.; Kadiri, M.; Boumediana, A.I.; Molero-Mesa, J.; Merzouki, A. Ethnobotanical study of medicinal plants in the Adrar Province, Mauritania. J. Ethnopharmacol. 2020, 246, 112217. [Google Scholar] [CrossRef] [PubMed]
  72. Ndhlovu, P.T.; Asong, J.A.; Omotayo, A.O.; Otang-Mbeng, W.; Aremu, A.O. Ethnobotanical survey of medicinal plants used by indigenous knowledge holders to manage healthcare needs in children. PLoS ONE 2023, 18, e0282113. [Google Scholar] [CrossRef] [PubMed]
  73. Abdulrahman, M. Ethnobotany of medicinal plants with antidiabetic potentials in Northern Nigeria. Eurasian J. Sci. Eng. 2021, 7, 46–58. [Google Scholar]
  74. Ajayi, T.O.; Attah, A.F.; Bafor, E.E.; Tokede, G.O. Ethnobotanical Survey of Medicinal Plants Used in the Management of Diabetes in Ibadan North-East and Ibadan South-East, Oyo State, Nigeria. Res. Sq. 2020, 1–24. [Google Scholar] [CrossRef]
  75. Schultz, F.; Anywar, G.; Wack, B.; Quave, C.L.; Garbe, L.-A. Ethnobotanical study of selected medicinal plants traditionally used in the rural Greater Mpigi region of Uganda. J. Ethnopharmacol. 2020, 256, 112742. [Google Scholar] [CrossRef]
  76. Tahraoui, A.; El-hilaly, J.; Ennabili, A.; Maache, S.; Laamech, J.; Lyoussi, B. Ethnobotanical Study of Medicinal Plants used by Traditional Health Practitioners to Manage Diabetes Mellitus in Safi and Essaouira Provinces (Central-Western Morocco). Trop. J. Nat. Prod. Res. 2023, 7, 2178. [Google Scholar]
  77. Segda, A.; Meda, R.N.-T.; Bangou, M.J.; Koama, B.K.; Ouoba, H.Y.; Kagambega, W.; Kam, S.E.; Ouedraogo, G.A. Ethnobotany of Medicinal Plants for Diabetes and Antioxidant Activity of Selected Phyllanthus amarus Schum and Thonn., Chrysanthellum americanum (L.) Vatke. and Striga hermonthica (Delile) Benth. of Burkina Faso. Nat. Prod. Chem. Res. 2023, 11, 1–7. [Google Scholar]
  78. Nyangono, N.; Soppo, L.; Nko’o, M.; Benga, M.; Maniepi, J.; Obono, F.; Obam, Y.E.; Noa, M.; Ndom, J.; Ngoa, L.E. Medicinal plants used by traditional practitioners for the treatment of diabetes, obesity and arterial hypertension in the Dja and Lobo Department of Cameroon. Saudi J. Med. Pharm. Sci. 2022, 8, 704–719. [Google Scholar]
  79. Uwimbabazi, M.; Kabonesa, B.; Ongarep, S.; Omujal, F.; Agaba, H. Ethnobotanical survey of medicinal plants used for the treatment of diabetes in Uganda. Ethnobot. Res. Appl. 2023, 26, 1–14. [Google Scholar] [CrossRef]
  80. Masunda, A.T.; Inkoto, C.L.; Bongo, G.N.; Wa Oloko, J.; Ngbolua, K.; Tshibangu, D.; Tshilanda, D.; Mpiana, P. Ethnobotanical and ecological studies of plants used in the treatment of diabetes in Kwango, Kongo central and Kinshasa in the Democratic Republic of the Congo. Int. J. Diabetes Endocrinol. 2019, 9, 18–25. [Google Scholar] [CrossRef]
  81. Naceiri Mrabti, H.; Bouyahya, A.; Naceiri Mrabti, N.; Jaradat, N.; Doudach, L.; Faouzi, M.E.A. Ethnobotanical survey of medicinal plants used by traditional healers to treat diabetes in the Taza region of Morocco. Evid. Based Complement. Altern. Med. 2021, 16, 5515634. [Google Scholar] [CrossRef] [PubMed]
  82. Arifah, F.H.; Nugroho, A.E.; Rohman, A.; Sujarwo, W. A review of medicinal plants for the treatment of diabetes mellitus: The case of Indonesia. S. Afr. J. Bot. 2022, 149, 537–558. [Google Scholar] [CrossRef]
  83. Giovannini, P.; Howes, M.-J.R.; Edwards, S.E. Medicinal plants used in the traditional management of diabetes and its sequelae in Central America: A review. J. Ethnopharmacol. 2016, 184, 58–71. [Google Scholar] [CrossRef] [PubMed]
  84. Van Wyk, B.E. A family-level floristic inventory and analysis of medicinal plants used in Traditional African Medicine. J. Ethnopharmacol. 2020, 249, 112351. [Google Scholar] [CrossRef] [PubMed]
  85. Ahmad, M.; Qureshi, R.; Arshad, M.; Khan, M.A.; Zafar, M. Traditional herbal remedies used for the treatment of diabetes from district Attock (Pakistan). Pak. J. Bot. 2009, 41, 2777–2782. [Google Scholar]
  86. Sathasivampillai, S.V.; Rajamanoharan, P.R.; Heinrich, M. Siddha medicine in eastern Sri Lanka today—Continuity and change in the treatment of diabetes. Front. Pharmacol. 2018, 9, 393631. [Google Scholar] [CrossRef]
  87. Sabiu, S.; Madende, M.; Ajao, A.A.-N.; Aladodo, R.A.; Nurain, I.O.; Ahmad, J.B. The Genus Allium (Amaryllidaceae: Alloideae): Features, phytoconstituents, and mechanisms of antidiabetic potential of Allium cepa and Allium sativum. Bioact. Food Diet. Interv. Diabetes 2019, 137–154. [Google Scholar]
  88. Feunaing, R.T.; Tamfu, A.N.; Ntchapda, F.; Gade, I.S.; Mbane, M.N.; Tagatsing, M.F.; Talla, E.; Henoumont, C.; Laurent, S.; Dinica, R.M. A new abietane-type diterpenoid from roots of Burkea africana Hook (Fabaceae) with α-amylase inhibitory potential. Nat. Prod. Res. 2022, 36, 4132–4139. [Google Scholar] [CrossRef] [PubMed]
  89. Sanou, Y.; Ouattara, L.; Kabre, P.; Ouedraogo, R.J.; Ouoba, P.; Zante, A.A.; Zoungo, D.; Somda, M.B.; Ouedraogo, A.G. Glucose adsorption capacity and inhibitory potential of Pseudocedrela kotschyi (Schweinf.) Harms (Meliaceae) leaf extracts against α-amylase: A comparative study over three months. J. Drug Deliv. Ther. 2023, 13, 134–140. [Google Scholar] [CrossRef]
  90. Bessada, S.M.F.; Barreira, J.C.M.; Oliveira, M.B.P. Asteraceae species with most prominent bioactivity and their potential applications: A review. Ind. Crops Prod. 2015, 76, 604–615. [Google Scholar] [CrossRef]
  91. Perez-Gutierrez, R.M.; Damian-Guzman, M. Meliacinolin: A potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice. Biol. Pharm. Bull. 2012, 35, 1516–1524. [Google Scholar] [CrossRef] [PubMed]
  92. Eidi, A.; Eidi, M.; Esmaeili, E. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine 2006, 13, 624–629. [Google Scholar] [CrossRef] [PubMed]
  93. WHO. Traditional Medicine Strategy; WHO: Geneva, Switzerland, 2002. [Google Scholar]
  94. Kharchoufa, L.; Merrouni, I.A.; Yamani, A.; Elachouri, M. Profile on medicinal plants used by the people of North- Eastern Morocco: Toxicity concerns. Toxicon 2018, 154, 90–113. [Google Scholar] [CrossRef]
  95. Ponnusankar, S.; Venkatesh, P.; Venkatesh, M.; Mandal, S.; Mukherjee, P.K. Herbal drugs require pharmacovigilance study-need and reality. Pharma Rev. 2007, 12, 113–120. [Google Scholar]
  96. Alzweiri, M.; Al Sarhan, A.; Mansi, K.; Hudaib, M.; Aburjai, T. Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region. J. Ethnopharmacol. 2011, 137, 27–35. [Google Scholar] [CrossRef]
  97. Gupta, R.; Bajpai, K.G.; Johri, S.; Saxena, A.M. An overview of Indian novel traditional medicinal plants with antidiabetic potentials. Afr. J. Tradit. Complement. Altern Med. 2008, 5, 1–17. [Google Scholar]
  98. Vujicic, T.; Cohall, D. Knowledge, Attitudes and Practices on the Use of Botanical Medicines in a Rural Caribbean Territory. Front. Pharmacol. 2021, 12, 713855. [Google Scholar] [CrossRef]
  99. Abe, R.; Ohtani, K. An ethnobotanical study of medicinal plants and traditional therapies on Batan Island, the Philippines. J. Ethnopharmacol. 2013, 145, 554–565. [Google Scholar] [CrossRef]
  100. Chege, I.N.; Okalebo, F.A.; Guantai, A.N.; Karanja, S.; Derese, S. Management of type 2 diabetes mellitus by traditional medicine practitioners in Kenya—Key informant interviews. Pan. Afr. Med. J. 2015, 22, 90. [Google Scholar] [CrossRef]
  101. Aadhan, K.; Anand, S. Survey of medicinal plants used for the treatment of diabetes by the Paliyar’s Tribe in Sadhuragiri hills, Tamil Nadu, India. Int. J. Herb. Med. 2017, 5, 17–25. [Google Scholar]
  102. Nuneza, O.; Rodriguez, B.; Nasiad, J.G. Ethnobotanical survey of medicinal plants used by the Mamanwa tribe of Surigao del Norte and Agusan del Norte, Mindanao, Philippines. Biodiversitas 2021, 22, 3284–3296. [Google Scholar] [CrossRef]
  103. Khan, I.; AbdElsalam, N.M.; Fouad, H.; Tariq, A.; Ullah, R.; Adnan, M. Application of ethnobotanical indices on the use of traditional medicines against common diseases. Evid. Based Complement. Alternat. Med. 2014, 2014, 635371. [Google Scholar] [CrossRef]
  104. Hamel, T.; Zaafour, M.; Boumendjel, M. Ethnomedical knowledge and traditional uses of aromatic and medicinal plants of the Wetlands Complex of the Guerbes-Sanhadja Plain (Wilaya of Skikda in Northeastern Algeria). Herb. Med. 2018, 4, 1–9. [Google Scholar] [CrossRef]
  105. Das, J.; Acharya, B.C.; Mallick, S.N. Traditional Ethno-Medicinal Plants Used for Treatment of Diabetes by Bhuyan Tribes in Sundargarh District of Odisha, India-An Ethnobotanical Survey. Plant Sci. Today 2023, 10, 58–67. [Google Scholar] [CrossRef]
  106. Amal, M.F.; Masarrat, M. Ethnobotanical Survey of Plants Used in the Treatment of Diabetes Mellitus in Tabuk Region, Saudi Arabia. Int. J. Curr. Microbiol. Appl. Sci. 2016, 5, 258–270. [Google Scholar]
  107. Alamgeer Younis, W.; Asif, H.; Sharif, A.; Riaz, H.; Bukhari, I.A.; Assiri, A.M. Traditional medicinal plants used for respiratory disorders in Pakistan: A review of the ethno-medicinal and pharmacological evidence. Chin. Med. 2018, 13, 48. [Google Scholar] [CrossRef]
  108. Chahad, A.M.; Michalet, S.; Bechir, A.B.; Tidjani, A.; Nkongmeneck, B.A.; Dijoux-Franca, M.G. Medicinal plants from the Ouaddaï Province (Chad): An ethnobotanical survey of plants used in traditional medicine. J. Altern. Complement. Med. 2015, 21, 569–577. [Google Scholar] [CrossRef]
  109. Hudaib, M.; Mohammad, M.; Bustanji, Y.; Tayyem, R.; Yousef, M.; Abuirjeie, M.; Aburjai, T. Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area. J. Ethnopharmacol. 2008, 120, 63–71. [Google Scholar] [CrossRef] [PubMed]
  110. Asase, A.; Yohonu, D.T. Ethnobotanical study of herbal medicines for management of diabetes mellitus in Dangme West District of southern Ghana. J. Herb. Med. 2016, 6, 204–209. [Google Scholar] [CrossRef]
  111. Lebbie, A.; Kouamé, F.; Kouassi, E. Specialization in ethnomedicinal plant knowledge among herbalists in the forest region of Rivercess County, Liberia. J. Med. Plants Res. 2017, 11, 264–274. [Google Scholar]
  112. Bailey, C.J. Metformin. historical overview. Diabetologia 2017, 60, 1566–1576. [Google Scholar] [CrossRef] [PubMed]
Plants 13 01898 g001
Figure 1. An overview of the procedure employed for the identification of the 39 published articles employed in this review.
Figure 1. An overview of the procedure employed for the identification of the 39 published articles employed in this review.
Plants 13 01898 g001
Plants 13 01898 g002
Figure 2. Frequencies (n) of plant families (n ≥ 3) utilized in the management of diabetes on the African continent. The rest of the plant families (n ≥ 2) are listed in Table 3.
Figure 2. Frequencies (n) of plant families (n ≥ 3) utilized in the management of diabetes on the African continent. The rest of the plant families (n ≥ 2) are listed in Table 3.
Plants 13 01898 g002
Plants 13 01898 g003
Figure 3. Frequencies (n) of the plant parts of the medicinal plants utilized in the management of diabetes on the African continent.
Figure 3. Frequencies (n) of the plant parts of the medicinal plants utilized in the management of diabetes on the African continent.
Plants 13 01898 g003
Plants 13 01898 g004
Figure 4. Frequencies (n) of the methods of preparation of the medicinal plants utilized in the management of diabetes on the African continent.
Figure 4. Frequencies (n) of the methods of preparation of the medicinal plants utilized in the management of diabetes on the African continent.
Plants 13 01898 g004
Plants 13 01898 g005
Figure 5. A pie chart showing the percentage of the route of the administration of the herbal medicines utilized in the management of diabetes on the African continent.
Figure 5. A pie chart showing the percentage of the route of the administration of the herbal medicines utilized in the management of diabetes on the African continent.
Plants 13 01898 g005
Table 3. An overview of the indigenous medicinal plants utilized in the management of diabetes in Africa.
Table 3. An overview of the indigenous medicinal plants utilized in the management of diabetes in Africa.
Botanical Name
(Family)		Country
(African
Regional Bloc)		Local Name(s)Part(s) UsedMethod(s) of PreparationRoute of
Administration		Reference
Allium sativum L.
(Amaryllidaceae)		Nigeria
(WAR)		Alubosa ayu (Yo)BulbGrindingNS[44]
Allium ascalonicum L.
(Amaryllidaceae)		Alubosa
Elewe (Yo)		BulbInfusionNS
Crinum jagus (J. Thomps.) Dandy
(Amaryllidaceae)		 Ogede odo (Yo)BulbMacerationNS
Gymnanthemum amygdalinum (Delile) Sch.
(Asteraceae)		Ewuro (Yo)LeavesMacerationNS
Azadirachta indica A.Juss
(Meliaceae)		Nigeria
(WAR)		Dogon yaro (Ha)Bark, leavesDecoctionOral[45]
Mangifera indica Lam.
(Anacardiaceae)		 Mangoroo (Ha)Bark, leavesDecoctionOral
Vernonia amygdalina Delile
(Asteraceae)		 Shiwaka (Ha)Leaves, stemGrindingOral
Allium sativum L.
(Amaryllidaceae)		South Africa
(SAR)		NSNSNSNS[46]
Aloe barbadensis miller
(Asphodelaceae)		 NSNSNSNS
Trigonella
foenum-graecum L.
(Fabaceae)		Algeria
(NAR)		Halba (Ar)SeedsInfusion Oral[47]
Artemisia herba-alba Asso
(Asteraceae)		Chih (Ar)LeavesInfusionOral
Allium sativum L.
(Amaryllidaceae)		Nigeria
(WAR)		Tafarnuwa (Ha)BulbNSNS[48]
Azadirachta indica A. Juss
(Meliaceae)		Dogon yaro (Ha)LeavesNSNS
Moringa oleifera Lam.
(Moringaceae)		 Zogale (Ha)LeavesNSNS
Allium cepa L.
(Amaryllidaceae)		Ghana
(WAR)		Onion (Tw)Bulb DecoctionOral[49]
Ampelocissus multistriata
(Baker) Planch.
(Asteraceae)		Awonwono (Tw)LeavesDecoctionOral
Morinda lucida A. Gray
(Rubiaceae)		 Konkoroma (Tw)LeavesDecoctionOral
Aloe barbadensis miller
(Asphodelaceae)		South Africa
(SAR)		Mokgoba (Ts), Inhlaba (Zu)LeavesDecoction, concoctionOral[11]
Hypoxis Hemerocallidea Fisch., C.A. Mey & Ave-Lall
(Hypoxidaceae)		Labatheka (Ts), inkomfe (Zu)RootsDecoction, concoctionOral
Artemisia herba-alba Asso
(Asteraceae)		Morocco
(NAR)		Chih (Ar)LeavesDecoctionNS[50]
Allium cepa L.
(Amaryllidaceae)		Elbessla (Ar)Bulb, seedsInfusionNS
Allium sativum L.
(Amaryllidaceae)		Nigeria
(WAR)		Ayuu (Yo)BulbDecoctionOral[51]
Vernonia amygdalina Delile
(Asteraceae)		 Ewuro (Yo)Leaves DecoctionOral
Coriandrum sativum L.
(Apiaceae)		Algeria
(NAR)		Kosbor (Ar)SeedsDecoction, infusionOral[52]
Linum usitatissimum L.
(Linaceae)		Zeriêet el
kettan
(Ar)		SeedsInfusion, powder Oral
Olea europaea L.
(Oleaceae)		Zitoun (Ar)LeavesInfusionOral
Allium sativum L.
(Amaryllidaceae)		Zambia
(SAR)		NSNSNSNS[53]
Moringa Oleifera Lam.
(Moringaceae)		NSNSNSNS
Moringa oleifera Lam.
(Moringaceae)		Nigeria
(WAR)		Ewe igbale (Yo)LeavesNSNS[54]
Azadirachta indica A. Juss
(Meliaceae)		Dongoyaro (Yo)Bark, leavesNSNS
Allium cepa L.
(Amaryllidaceae)		Algeria
(NAR)		Bassel (Ar)Bulb GrindingOral[55]
Trigonella foenum-graecum L.
(Fabaceae)		Helba (Ar)SeedsInfusion, decoctionOral
Cinnamomum verum J. Presl
(Lauraceae)		Quarfa (NS)BarkInfusion, maceration, powderOral
Olea europaea L.
(Oleaceae)		 Zeytoune (NS)LeavesInfusion, powderOral
Olea europeae L.
(Oleaceae)		Morocco
(NAR)		Zaytoun (Ar)LeavesInfusion, powderOral[56]
Trigonella foenum-graecum L.
(Fabaceae)		Lhelba (Ar)SeedsDecoctionOral
Thymus satureioides Coss. et Bal.
(Lamiaceae)		 Z’itra (Ar)LeavesDecoction, infusionOral
Sida acuta Burman f.
(Malvaceae)		Tanzania
(EAR)		Tevere (NS)LeavesDecoctionOral[57]
Parinari Planch.ex Benth.
Curatellifolia
(Rosaceae)		 Mnazipori (NS)RootsInfusionOral
Opuntia ficus-indica
(L.) Mill.,
(Cataceae)		Zimbabwe
(SAR)		Mudhorofiya (Sh)LeavesDecoctionOral[58]
Cassia occidentalis
(Linn)
(Fabaceae)		Sierra Leone
(WAR)		E-sabe (Ti)LeavesDecoctionOral[59]
Mangifera indica Lam.
(Anacardiaceae)		Mangro (Ka)LeavesDecoctionOral
Moringa Oleifera Lam.
(Moringaceae)		Angola
(SAR)		Moringa (NS)Leaves, seeds, rootsInfusion, decoctionOral[60]
Azadirachta indica A. Juss.
(Meliaceae)		Neem (NS)LeavesInfusion, macerationOral
Azadirachta indica A. Juss.
(Meliaceae)		Sudan
(NAR)		Neem (Hd)RootsMacerationOral[61]
Kalanchoe glaucescens Britten
(Crassulaceae)		Malut (Hd)LeavesInfusionOral
Urtica dioica L.
(Urticaceae)		Morocco
(NAR)		Herriga
(thayzint) (Th)		LeavesDecoctionNS[62]
Olea europaea L.
(Oleaceae)		Azamour (Th)LeavesDecoction, infusionNS
Leptadenia hastata (Pers.) Decne
(Apocynaceae)		Ghana
(WAR)		Yaadiya (Tw)LeavesDecoctionNS[63]
Pricralima nitida
Durand & Hook
(Apocynaceae)		 Abere (Tw)RootsDecoctionNS
Olea europaea L.
(Oleaceae)		Morocco
(NAR)		Zitoun (Ha)LeavesInfusionOral[64]
Silvia officinalis L
(Lamiaceae)		 Salmia (Ha)Stem, flowersDecoction, powderOral
Garcinia kola Hackel.
(Clusiaceae)		Democratic Republic of Congo
(EAR)		Butenth (Wo), Nten (Mb)Fruit, barkDecoction, macerationOral[65]
Pancovia laurentii (De
Wild.) Gilg
(Sapendaceae)		Irweth (Wo)BarkDecoctionOral
Securidaca
Longipedunculata Fresen
(Polygalaceae)		Nigeria
(WAR)		NSStem, barkNSNS[66]
Pennisetum pendicellatum Trin.
(Poaceae)		NSStem, barkNSNS
Trigonella foenumgraecum L.
(Fabaceae)		Morocco
(NAR)		Lhelbah (Ar)SeedsDecoction, powderNS[67]
Verbena officinalis L.
(Verbenaceae)		 Allouiza
(Ar)		LeavesDecoction, infusionNS
Olea europaea L.
(Oleaceae)		Morocco
(NAR)		NSNSNSNS[68]
Crossopteryx febrifuga (Afzel.
ex G. Don) Benth.
(Rubiaceae)		Tanzania
(EAR)		Nakasabuni
(Ya)		Roots, barkDecoctionNS[69]
Maprounea africana Müll. Arg
(Euphorbiaceae)		Mtunu (Ya)RootsDecoctionOral
Moringa oleifera Lam.
(Moringaceae)		South Africa
(SAR)		NSNSNSNS[70]
Abelmoschus esculentus (L.) Moench
(Malvaceae)		NSNSNSNS
Ocimum basilicum L.
(Lamiaceae)		Mauritania
(WAR)		I.hbaq (Hs)LeavesDecoctionOral[71]
Ziziphus lotus (L.) Lam.
(Rhamnaceae)		 Hreytek (Hs)LeavesInfusionOral
Opuntia ficus-indica
(L.) Mill.,
(Cataceae)		South Africa
(SAR)		Toorofeye (Ts)LeavesMacerationOral[72]
Commiphora
kerstingii Engl.
(Burseraceae)		Nigeria
(WAR)		Ararrabi (Ha)LeavesNSNS[73]
Khaye senegalensis Desr.
(Meliaceae)		Madachi (HaBarkNSNS
Hunteria umbellate (K. Schum) Haller. F
(Apocynaceae)		Nigeria
(WAR)		Abeere (Yo)NSNSNS[74]
Momordica charantia Descourt.
(Cucurbitaceae)		Ejinrin (Yo)NSNSNS
Erythrina abyssinica Lam. ex DC.
(Fabaceae)		Uganda
(EAR)		NSBarkNSNS[75]
Ficus saussureana DC.
(Moraceae)		NSLeavesNSNS
Allium sativum L.
Alliaceae		Morocco
(NAR)		tūma, tiskert (Ar)BulbMaceration, powderNS[76]
Carum carvi L.
(Apiaceae)		Karwiyâ (Ar)FruitDecoction, infusionNS
Cassia sieberiana DC.
(Fabaceae)		Burkina Faso
(WAR)		Sindjan
(Di)		Roots, barkDecoction, powderOral[77]
Chrysanthellum
americanum (L.) Vatke.
(Asteraceae)		Waltuko
(Mo)		LeavesDecoctionOral
Phaseolus Vulgaris L.
(Fabaceae)		Cameroun (CAR)Evele kone (Bu)NSMacerationOral[78]
Aloe barbadensis miller
(Liliaceae)		 Aloe vera (Bu)LeavesDecoctionOral
Allium cepa L.
(Amaryllidaceae)		Uganda
(EAR)		NSBuNSNS[79]
Mangifera indica L.
(Anacardiaceae)		NSLeaves, barkNSNS
Allium cepa L.
(Amaryllidaceae)		Democratic Republic of Congo
(EAR)		Litungulu (NS)BulbMacerationNS[80]
Mangifera indica L.
(Anacardiaceae)		Manga (NS)LeavesDecoctionNS
Persea americana Mill.
(Lauraceae)		Divoka (NS)LeavesDecoctionNS
Foeniculum vulgare Mill.
(Apiaceae)		Morocco
(NAR)		Nafaa (Dr)SeedsDecoction Oral[81]
Taraxacum officinale L.
(Asteraceae)		 Garnina (Dr)Leaves, roots, stemDecoction, powderOral
Local names of indigenous medicinal plants (specific to assigned countries) utilized in the management of diabetes in the various African countries: Arabic (Ar); Bulu (Bu); Dioula (Di); Darija (Dr); Hausa (Ha); Hadendowa (Hd); Hassani (Hi); Hassanya (Hs); Mbuu (Mb); Moore (Mo); not stated (NS); Shona (Sh); Tharifit (Th); Tswana (Ts); Twi (Tw); Wongo (Wo); Yao (Ya); Yoruba (Yo); Zulu (ZU). Regional blocs of African countries based on their locations on the continent: Central African Region (CAR); Eastern African Region (EAR); Northern African Region (NAR); Southern African Region (SAR); Western African Region (WAR).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Frimpong, E.K.; Thembane, N.; Hlatshwayo, S.; Ngcobo, M.; Gqaleni, N. Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective. Plants 2024, 13, 1898. https://doi.org/10.3390/plants13141898

AMA Style

Frimpong EK, Thembane N, Hlatshwayo S, Ngcobo M, Gqaleni N. Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective. Plants. 2024; 13(14):1898. https://doi.org/10.3390/plants13141898

Chicago/Turabian Style

Frimpong, Ebenezer Kwabena, Nokukhanya Thembane, Sphamandla Hlatshwayo, Mlungisi Ngcobo, and Nceba Gqaleni. 2024. "Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective" Plants 13, no. 14: 1898. https://doi.org/10.3390/plants13141898

APA Style

Frimpong, E. K., Thembane, N., Hlatshwayo, S., Ngcobo, M., & Gqaleni, N. (2024). Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective. Plants, 13(14), 1898. https://doi.org/10.3390/plants13141898

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop